Generation of Glia-Enriched Brain Organoids with Oligodendrocyte Differentiation and Microglia Integration for MS Disease Modeling
Source Fagiani et al., 2024 · IRCCS San Raffaele Scientific Institute, Milan, Italy · 10.1016/j.xcrm.2024.101680
Abstract
This protocol generates glia-enriched 3D forebrain organoids from hiPSC-derived neural precursor cells using doxycycline-inducible SOX10 expression to accelerate oligodendrocyte differentiation. Mature organoids containing neurons, astrocytes, oligodendrocytes, and integrated hiPSC-derived microglia are obtained within 8 weeks and can be exposed to MS-patient CSF to model chronic active lesion phenotypes for drug screening.
Protocol overview
21 steps across 5 phases
- 1 Culture and expansion of hiPSC-derived NPCs
- 2 Seed NPCs in T25 flasks for viral infection
- 3 First viral infection of NPCs
- 4 Second viral infection of NPCs
- 5 Doxycycline induction and GFP expression
- 6 FACS sorting of GFP+ cells
- 1 Plate NPCs for organoid formation
- 2 Culture NPCs in Reinhardt medium
- 3 Switch to glial induction medium (GIM)
- 4 Maintain GIM culture with doxycycline
- 5 Switch to glial differentiation medium (GDM)
- 1 Continue GDM culture with doxycycline
- 2 Add BDNF and GDNF at day 14
- 3 Discontinue doxycycline at day 14
- 1 Continue GDM culture without doxycycline
- 2 Differentiate hiPSC-derived microglia in parallel
- 3 Integrate microglia into 8-week-old organoids
- 1 Prepare MS-inflamed cerebrospinal fluid (CSF)
- 2 Expose organoids to MS-inflamed CSF
- 3 Harvest organoids for molecular analysis at 24 hours
- 4 Harvest organoids for cellular and microscopy analysis at 6 days
Full SOP
Create a free account to access this protocol
Join OrganMatch to unlock step-by-step procedures, reagent concentrations, QC checklists, and downloadable batch record templates.
Create free accountAlready registered? Log in
Attribution
This SOP was authored by Organthis based on the published method in Fagiani et al., 2024. The originating laboratory holds no rights in this SOP and has not endorsed it unless marked Verified.
This wording is awaiting legal review.
Something wrong with this entry? Report an issue with this protocol